Discovery of Novel 4-Arylisochromenes as Anticancer Agents Inhibiting Tubulin Polymerization-Reference-Cited by-同舟云学术

Discovery of Novel 4-Arylisochromenes as Anticancer Agents Inhibiting Tubulin Polymerization

Published:2018-09-25 Issue:10 Volume:9 Page:974-979
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Li Wenlong¹,Shuai Wen¹,Xu Feijie¹,Sun Honghao¹,Xu Shengtao¹,Yao Hong¹,Liu Jie²,Yao Hequan¹,Zhu Zheying³,Xu Jinyi¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry and State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, P. R. China

2. Department of Organic Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, P. R. China

3. Division of Molecular Therapeutics & Formulation, School of Pharmacy, The University of Nottingham, University Park Campus, Nottingham NG7 2RD, U.K.

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

State Key Laboratory of Natural Medicines, China Pharmaceutical University

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.8b00217

Reference33 articles.

1. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4